Document ID: chunk:federal_register_of_legislation:C2024C00632:section:61:p5
Version: federal_register_of_legislation:C2024C00632
Segment Type: section
Provision Reference: s 61 (pt 5/5)
Character Range: 1140031–1142137

application relates.
 (8C) If, under the regulations, a person is liable to pay a fee in respect of an application for information, the Secretary must notify the person, in writing, accordingly, and must give to the person, together with that notification, a statement setting out the basis on which the amount of that fee is calculated.
 (9) Despite subsection 14(2) of the Legislation Act 2003, an instrument under subsection (5AB), (5D), (7B) or (7D) of this section may make provision in relation to a matter by applying, adopting or incorporating, with or without modification, any matter contained in an instrument or other writing as in force or existing from time to time.
 (10) Nothing in this or any other Act requires the Secretary to disclose to any person, court or tribunal information referred to in subsection 25(2E) (including as that subsection applies because of subsection 32DE(2) or 32EB(3)) or 26(2D) if the disclosure would constitute a breach of the Mutual Recognition Convention.
 (11) This section (except subsection (10)) has effect subject to the Freedom of Information Act 1982.
 (12) The subsections of this section permitting the release of information have effect independently of each other.
 (13) The Secretary is not required to observe any requirements of the natural justice hearing rule in relation to:
 (a) releasing information under subsection (5C) if:
 (i) the release of the information is in the interests of public health or safety; or
 (ii) the information relates to the safety of one or more therapeutic goods; or
 (b) releasing information under any other provision of this section.
 (14) Subsection (13) is not to be taken to imply that the natural justice hearing rule applies in relation to any other exercise of power under this Act (including this section) or the regulations.
 (15) For the purposes of subparagraph (13)(a)(i), the release of information is not in the interests of public health or safety if the information:
 (a) relates to the quality or efficacy of therapeutic goods; and
 (b) does not relate to the safety of the therapeutic goods.